Development of human single-domain antibodies against influenza based on NA-targeting IgG
Biochemical and Biophysical Research Communications · 2026
DOI: 10.1016/j.bbrc.2026.153238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Ailing Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Analysis and Control of Zoonotic Pathogenic Microorganism, College of Life Sciences, Hebei Agricultural University, Hebei, 07…. Hauptthemen laut MEDLINE: Immunoglobulin G, Single-Domain Antibodies, Neuraminidase, Influenza, Human. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Baoding City Science and Technology and Intellectual Property Bureau, Hebei Provincial Natural Science Foundation.
Abstract (Originalsprache)
The neuraminidase (NA) of influenza A virus (IAV) is an important antiviral target. However, antibodies require precise recognition of the catalytic pocket to exert antiviral effects, making them difficult to obtain through conventional screening. Traditional IgG antibodies also suffer from poor aerosolization efficiency, limiting their effectiveness for respiratory delivery. Human single-domain antibodies (sdAbs) with only the variable domain of the heavy chain (VH) show great potential in combating respiratory viral infections because of their small molecular weight and superior inhalable properties; however, sdAbs often lose stability or binding activity when isolated directly from parental IgG antibodies. To overcome these barriers and accelerate the acquisition of fully human sdAbs targeting the NA active pocket, we extracted the VH domain from broadly neutralizing anti-NA IgG and applied scaffold grafting followed by affinity recovery. Ultimately, we obtained two fully human sdAbs with favorable physicochemical properties that inhibited H5N8 NA enzymatic activity, with IC50 values of 0.82 and 0.59 μg mL-1. This work enabled the originally insoluble VH fragment of IgG to be expressed in a stable and soluble form and restored its NA-binding activity from undetectable levels to the nanomolar range, providing insights into engineering fully human sdAbs capable of targeting structurally constrained viral enzymes and suitable for inhalable influenza therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hebei Key Laboratory of Analysis and Control of Zoonotic Pathogenic Microorganism, College of Life Sciences, Hebei Agricultural University, Hebei, 071001, China.
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China; Shanghai Engineering Re…
- Hebei Key Laboratory of Analysis and Control of Zoonotic Pathogenic Microorganism, College of Life Sciences, Hebei Agricultural University, Hebei, 071001, China. Electronic address: shmyf@hebau.edu.cn.
Förderung
- National Natural Science Foundation of China
- Baoding City Science and Technology and Intellectual Property Bureau
- Hebei Provincial Natural Science Foundation
Zitieren
APA
Huang, A., Li, C., Wu, H., Sun, W., Huo, S., Wang, J., Wu, Y., Ying, T., & Yu, F. (2026). Development of human single-domain antibodies against influenza based on NA-targeting IgG. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2026.153238
Vancouver
Huang A, Li C, Wu H, Sun W, Huo S, Wang J, et al. Development of human single-domain antibodies against influenza based on NA-targeting IgG. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2026.153238
BibTeX
@article{Huang2026,
author = {Huang, Ailing and Li, Cheng and Wu, Hui and Sun, Wenli and Huo, Shanshan and Wang, Juan and Wu, Yanling and Ying, Tianlei and Yu, Fei},
title = {Development of human single-domain antibodies against influenza based on NA-targeting IgG},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
doi = {10.1016/j.bbrc.2026.153238}
}
EUVIMED